We are currently seeking strategic alliances with pharmaceutical manufacturers and small biotech development companies who are interested in:

• Orphan pharmaceutical development
• Clinical development
• Pre-approval distribution of orphan drugs through third-party contractors in accordance with
  governmental regulations
• Accelerated registration in the United States, Canada, Mexico, and South America
• Targeted, efficient sales and distribution
• Secure and rapid delivery of products
• Single-source distribution
• Pricing and reimbursement strategies to optimize product utilization
• Orphan product regulatory maintenance

Through creative strategic alliances, as well as unique relationships with the government, research institutions, physicians, scientists, and manufacturers, we look to provide options where there are no options—and therapies where there are no therapies.